Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
52.9M
-
Shares change
-
+11.1M
-
Total reported value, excl. options
-
$3.52B
-
Value change
-
+$773M
-
Put/Call ratio
-
0.08
-
Number of buys
-
109
-
Number of sells
-
-28
-
Price
-
$66.45
Significant Holders of Apogee Therapeutics, Inc. - Common Stock (APGE) as of Q1 2024
149 filings reported holding APGE - Apogee Therapeutics, Inc. - Common Stock as of Q1 2024.
Apogee Therapeutics, Inc. - Common Stock (APGE) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.9M shares
.
Largest 10 shareholders include VR Adviser, LLC (8.49M shares), FMR LLC (6.74M shares), BlackRock Inc. (2.81M shares), RTW INVESTMENTS, LP (2.47M shares), Deep Track Capital, LP (2.32M shares), WELLINGTON MANAGEMENT GROUP LLP (2.27M shares), Driehaus Capital Management LLC (2.06M shares), PERCEPTIVE ADVISORS LLC (2.06M shares), Fairmount Funds Management LLC (2.05M shares), and RA CAPITAL MANAGEMENT, L.P. (1.98M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.